Claim Missing Document
Check
Articles

Found 4 Documents
Search

Congolese Medicinal Plant biodiversity as Source of AntiCOVID-19 Compounds: Economic goods in the light of Comparative Advantages Theory of Ricardo Modeste Ndaba Modeawi; Ruphin Djolu Djoza; Colette Masengo Ashande; Clarisse Falanga Mawi; Emmanuel Moke Lengbiye; Clément Inkoto Liyongo; Benjamin Gbolo Zoawe; Muhammad Ridwan; Pius T. Mpiana; Mudogo Virima; Koto-te-Nyiwa Ngbolua
Budapest International Research in Exact Sciences (BirEx) Journal Vol 2, No 3 (2020): Budapest International Research in Exact Sciences, July
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birex.v2i3.1067

Abstract

Since the outbreak of Covid-19 (Corona virus) in China in December 2019, the disease has killed more people in Europa, America and Asia according to official sources.  Less impacted than the rest of the world, Africa as well as Oceania has less confirmed cases and less deaths. In countries whose health systems are among the most fragile in the world, with far less resources than those mobilized in Europe, China or the United States, the situation in Africa is potentially catastrophic. Since human and material resources, such as hospitalization and intensive care beds, are largely insufficient, the mortality rate linked to Covid-19 is likely to be 3 to 5 times higher than in the rest of the world. In the face of this evidence, scientific research based on medicinal plants would be seen as no less important part of the solution to the Covid-19 pandemic, based on plant biodiversity. The Malagasy Institute of Applied Research (IMRA/Madagascar) on the basis of the Artemisia annua has set up Covid-Organics; The Congolese plant biodiversity offers undeniable advantages for the setting up of an Improved Traditional Medicine following the example of Covid-Organics. This would constitute for the Democratic Republic of the Congo a comparative advantage to be put forward in its multiple international exchanges.
Ethnobotanical Value of Myrianthus arboreus Used in Traditional Medicine by the Ngbaka Tribe (South-Ubangi), Democratic Republic of the Congo Pascal N. Bobuya; Jetron M. Ngbolondo; Jean Pierre K.A. Zwave; Colette Masengo Ashande; Muhammad Ridwan; Koto-Te-Nyiwa Ngbolua
Budapest International Research in Exact Sciences (BirEx) Journal Vol 4, No 4 (2022): Budapest International Research in Exact Sciences, October
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birex.v4i4.7128

Abstract

The aim of this study is to contribute to a better knowledge of the use of M. arboreus as a medicinal plant traditionally used in the treatment of common diseases by the Ngbaka people in the South Ubangi, Democratic Republic of the Congo. Based on free consent of the respondents, an ethnobotanical survey was carried out using a questionnaire among the Ngbaka healers. The aim of this study is to contribute to a better understanding of the use of M. arboreus as a medicinal plant traditionally used in the treatment of common diseases by the Ngbaka people in the South Ubangi. Based on consent of the respondents, an ethnobotanical survey was carried out using a questionnaire among the Ngbaka healers. The results obtained in this study allowed us to identify 23 diseases that are treated by Myrianthus arboreus. The organs of M. arboreus used for the treatment of diseases are mainly the leaf (96%), the bark of the stem (66%), the fruits and seeds (42%) and the roots (34%). The main methods of preparation of the organs were decoction (86%) and maceration (66%), while the administration of the recipes is predominantly via oral (86%) and cutaneous route (68%). The vast majority of respondents use M. arboreus organs for the treatment of abscesses (17 citations), sinusitis (15 citations) and tooth decay (15 citations), and wounds with 13 citations.  This work provides a source of information that can be used as a basis for pharmacological studies to assess therapeutic effectiveness.
A Review on Some Wound Healing Plants Traditionally Used in Democratic Republic of the Congo Michel Mongeke Mobale; Jean-Paul Koto-Te-Nyiwa Ngbolua; Antoine Mumba Djamba; Elodie Mubikayi Jeannine; Monizi Mawunu; Colette Masengo Ashande; Pius T. Mpiana
Budapest International Research in Exact Sciences (BirEx) Journal Vol 5, No 1 (2023): Budapest International Research in Exact Sciences, January
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birex.v5i1.7479

Abstract

Plants have been used by humans as a primary source of care in medicine since ancient times. Currently, about 80% of the population in southern Africa uses traditional medicine to meet their primary healthcare needs. The aim of this study was to document the healing plants traditionally used in the Democratic Republic of Congo. A systematic analysis and review of the virtual and physical literature search was conducted on the research literature related to healing medicinal plants used in the Democratic Republic of Congo. The results of the study reveal a total of 53 medicinal plants distributed in 50 genera and 31 families used for healing human wounds. The most represented families are Asteraceae (7 species), Euphorbiaceae (5 species), Rubiaceae (5 species), and Lialliaceae (3 species). Concerning the species abundance, the most represented genera are Allium (2 species), Morinda (2 species), and Vernonia (2 species). Herbaceous (39.6%, 21 species), shrubs (32.1%, 17 species) and trees (20.8%, 11 species), lianas (5.7%, 3 species), shrubs (1.9%, 1 species) are the main morphological types documented. Moreover, leaves and barks are the plant organs most used in healing. Thus, the documented therapeutic use of these plants provides the first baseline data for the city, and unveils further avenues of research into pharmacological and conservation studies.
Serious Side Effects Associated with the Administration of Johnson & Johnson COVID-19 Antigens after Immunisation: A Case Report from the Wapinda Health Area (North-Ubangi) in the Democratic Republic of the Congo Vincent Danvene Gonda; Modeste Ndaba Modeawi; Ruphin Djolu Djoza; Colette Masengo Ashande; Koto-Te-Nyiwa Jean-Paul Ngbolua
Britain International of Exact Sciences (BIoEx) Journal Vol 6 No 1 (2024): Britain International of Exact Sciences Journal, January
Publisher : Britain International for Academic Research (BIAR) Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/bioex.v6i1.1040

Abstract

On March 10, 2020, the Democratic Republic of the Congo (DRC) declared the onset of the COVID-19 pandemic. Since then, there have been a total of 95,738 cases, comprising 95,736 confirmed cases and 2 probable cases, with 84,321 recoveries and 1,464 fatalities. Following the guidance of the World Health Organization (WHO), African nations have been actively working to establish and expand vaccination programs. Starting the vaccination campaign in the DRC on April 19, 2021, a total of 10,893,593 individuals, estimated to be 20.18% of the target population, have received vaccines. Among them, 882,106 individuals, or 1.65%, have received their first dose, while 8,576,320 individuals or 15.89% of the target population, and have been fully vaccinated. The Democratic Republic of the Congo aims to vaccinate 53.9 million people against COVID-19, according to the technical response secretariat. This article focuses on the post-vaccination symptoms observed in a resident of the Wapinda sector, Yakoma territory in Nord-Ubangi Province, which has raised curiosity and serves as the subject of discussion.